Indiana’s death toll from COVID-19 surpasses 5,000
The Indiana State Department of Health on Sunday reported 6,255 new COVID-19 cases, the 12th straight day that the state has reported more than 5,000 new cases.

The Indiana State Department of Health on Sunday reported 6,255 new COVID-19 cases, the 12th straight day that the state has reported more than 5,000 new cases.
It is the second drug of this type—called a monoclonal antibody—to be cleared for COVID-19. The FDA authorized Eli Lilly and Co.’s drug on Nov. 9.
The state on Saturday reported 40 new COVID-19 deaths, raising the cumulative total during the pandemic to 4,992.
While an effective vaccine is expected to be widely distributed in 2021, surging U.S. infections are causing renewed angst as government officials re-impose the kind of restrictions that squelched the economy and roiled markets earlier this year.
The Governor’s Office said the couple will continue their 14-day quarantine and can resume a normal schedule with vigilance about masking and social distancing on Dec. 1.
The pandemic has reshaped the most important shopping season of the year, forcing retailers to rethink inventory, store layouts and when, even how, they offer their deepest discounts.
U.S. Treasury Secretary Steven Mnuchin said a decision to end several emergency loan programs being run by the Federal Reserve was based on the fact that the programs were not being heavily utilized.
A surge in coronavirus cases has local restaurateurs fretting that public officials are on the cusp of imposing severe restrictions that they say will force hundreds of local eateries to close.
Eateries are digging deep and thinking creatively to try to hang on. IBJ looks at the strategies employed by Beholder, Shapiro’s Delicatessen, Gomez BBQ and Azzip Pizza.
The sites serve as hubs where small groups of students are provided weekday virtual learning supervision and support at no cost to families.
COVID-19 patients occupy nearly 42% of Indiana’s intensive care beds. The state said only 21.6% of its ICU beds are unoccupied.
Indiana’s unemployment rate has been doggedly retracing its steps in recent months from 16.9% in April, when the pandemic paralyzed sections of the economy.
In a separate development, the FDA on Thursday gave emergency authorization to use of another anti-inflammatory drug sold by Eli Lilly, baricitinib, to be used with remdesivir.
The action comes days after Pfizer Inc. and its German partner BioNTech announced that its vaccine appears 95% effective at preventing mild to severe COVID-19 disease in a large, ongoing study.
Owner Tom Main, 63, said he contacted a broker to put the business on the market. The asking price is $1.2 million, which includes both the business and the 900-square-foot building it occupies in Herron-Morton Place.
Without data to paint a picture of academic success or failure, Indianapolis Public Schools will likely delay for a year renewing the contracts of four privately run schools under its supervision.
The CDC issued the recommendations just one week before Thanksgiving, at a time when diagnosed infections, hospitalizations and deaths are skyrocketing across the country.
Tyson Foods suspended top officials at its largest pork plant on Thursday and launched an investigation into allegations that they bet on how many workers would get infected during a widespread coronavirus outbreak.
The central bank said it “would prefer that the full suite of emergency facilities established during the coronavirus pandemic continue to serve their important role as a backstop for our still-strained and vulnerable economy.”
The Indianapolis drugmaker said Thursday evening it was awarded an emergency use authorization for its drug baricitinib to be used in combination with Gilead Sciences’ antiviral drug remdesivir in severely ill, hospitalized patients with COVID-19.